Navigation Links
Researchers focus on secondary stroke prevention after study reveals room for improvement
Date:9/12/2011

g stroke, assessing compliance issues from the patients' perspective, as well as system and provider issues, such as what type of doctor the patients saw, what kind of follow up care they had and the patients' understanding of their medications and why they were taking them.

The researchers first studied 2,598 patients from the AVAIL Registry to evaluate how many stroke patients were still taking their secondary prevention medications three months after being discharged from the hospital.

The three-month data appeared in the December 2010 issue of Archives of Neurology, and revealed that about 75 percent of those studied had continued with their full regimen of medications usually including an aspirin or other type of blood thinner, blood pressure medication and cholesterol lowering medication three months after discharge.

The one-year data evaluated "persistence," defined as continuation of all secondary stroke prevention medications prescribed at hospital discharge, and "adherence," defined as continuation of all prescribed medications except those stopped according to healthcare provider instructions, to get a true read on whether patients no longer on their medications are discontinuing on their own, or if they are being told by their doctors to stop their secondary prevention regimen.

Of the 2,457 patients who completed one-year interviews, 65.9 percent were "persistent" with their secondary prevention regimen, meaning they were still taking all of the medicines prescribed to them at hospital discharge. Even more patients 86.6 percent were "adherent," following doctor's orders and taking all of their medications except those they had been told to discontinue by their healthcare providers.

Although up to one third of stroke patients were no longer taking one or more of their secondary prevention medications within one year of hospital discharge, most did not stop taking the medications on their own, the study a
'/>"/>

Contact: Jessica Guenzel
jguenzel@wakehealth.edu
336-716-3487
Wake Forest Baptist Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Moffitt Cancer Center researchers use new tool to counter multiple myeloma drug resistance
2. Researchers find process that clears cholesterol and could reverse major cause of heart attack
3. Aerobic exercise may reduce the risk of dementia, Mayo Clinic researchers say
4. MU researchers use new video gaming technology to detect illness, prevent falls in older adults
5. Researchers develop new way to predict heart transplant survival
6. Researchers investigate new mechanism for predicting how diseases spread
7. Researchers successfully perform first injection of cultured red blood cells in human donor
8. Researchers share discoveries about aging-related changes in health and cognition
9. UC Davis researchers develop computer model for testing heart-disease drugs
10. Stanford researchers invent sutureless method for joining blood vessels
11. Yale researchers use genetic code to engineer a living protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – Forecast ... treatment landscape, unmet needs, current pipeline and commercial opportunities ... drug which is typically used for treating colorectal cancer. ... treating gastric cancer and pancreatic cancer. TS-1 is composed ... first approved in 1999 in Japan for the treatment ...
(Date:12/25/2014)... Angeles, CA (PRWEB) December 25, 2014 The ... Dolcemaschio was created in honor of a true 9/11 ... at two film festivals including the 24 hours of Nuremberg ... Festival in Bangladesh. , Actress, screenwriter and director ... helped produce this film together with her husband, Gregory ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, LunaDress.co.uk has updated ... dresses and related accessories. Now, all of the models at LunaDress.co.uk ... moment a groom lifts the wedding veil can turn out to ... stunning charm. A wedding veil can always bring surprise to a ... suggestions on how to choose veils for a big day ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... a "fountain of youth" drug that can delay the effects ... new study suggests. Seniors received a significant boost to ... genetic signaling pathway linked to aging and immune function, researchers ... experimental medication, a version of the drug rapamycin, improved the ...
(Date:12/25/2014)... 25, 2014 Residents at ... recently showed their generous spirit by providing holiday ... County Parenting Network- Grandparents Raising Grandchildren program. , ... around the largest Christmas tree on the campus ... by residents of the Abernethy Village Association (AVA). ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Retirement Community Residents Make Impact During Holiday Season 2
... ... an all-new chapter, Dating Games Men Play: 16 Men,s Deadly Dating Patterns that will help ... book also includes specific dating advice for single mothers, women over 45, successful professionals and ... (PRWEB) January 28, ...
... ... Sunquest Collection Manager™ automated specimen collection software , ... (PRWEB) January 28, 2010 -- ... announced that Valley Medical Center, in Renton, Washington, has licensed Sunquest ...
... Bella’s House Community ... in and around the Houston, TX area. We have added two new ways parents can ... ... Community News is dedicated to supporting parents with special needs children by acting as a ...
... identified several cytokines, cytokine-related factors, and chemokines that increase ... These findings confirm those of earlier studies which suggest ... and disease progression may be prevented. Complete findings of ... Arthritis & Rheumatism , a journal of the ...
... new study led by Mount Sinai researchers in collaboration ... for Disease Control and Prevention, has found higher prenatal ... be connected with disruptive and problem behaviors in children ... study, which is the first to examine the effects ...
... 30 Groups Emphasize The Urgency Of Repealing Medicare ... Americans , WASHINGTON , Jan. 27 ... professionals and providers recently sent a letter to Congressional ... process for Medicare Part B outpatient therapy services. Without ...
Cached Medicine News:Health News:New Paperback Dating Advice Book, Love in 90 Days, Reveals 16 Men's Dead-End Dating Patterns and What To Do About Them 2Health News:New Paperback Dating Advice Book, Love in 90 Days, Reveals 16 Men's Dead-End Dating Patterns and What To Do About Them 3Health News:Sunquest Information Systems Enters Into Business Relationship with Valley Medical Center of Washington 2Health News:Announcing the Launch of a New Workshop and Forum for Parents of Disabled Children 2Health News:Announcing the Launch of a New Workshop and Forum for Parents of Disabled Children 3Health News:Blood test can predict rheumatoid arthritis before symptoms arise 2Health News:Mount Sinai finds prenatal exposure to certain chemicals affects childhood neurodevelopment 2Health News:Congress Urged to Take Immediate Action to Ensure Frail Patients Continue to Receive Critical Therapy Services 2Health News:Congress Urged to Take Immediate Action to Ensure Frail Patients Continue to Receive Critical Therapy Services 3
(Date:12/24/2014)... , Dec. 24, 2014  Actavis plc (NYSE: ... Company has received a complete response letter from ... its New Drug Application (NDA) for the fixed-dose ... treatment of hypertension.   Photo - ... disappointed in the receipt of a complete response ...
(Date:12/24/2014)... CHENGDU, China, Dec. 24, 2014 /PRNewswire/  -- Tianyin ... a pharmaceutical company that specializes in the patented ... and active pharmaceutical ingredients (API) released unaudited preliminary ... year 2015. Fiscal Year 2015 Ended ... was $9.7 million compared with $14.7 million in ...
(Date:12/24/2014)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... that address unmet medical needs in the areas ... on December 24, 2014 it closed its previously ... raised approximately $2.3 million in gross proceeds from ... proceeds from the offering to fund its research ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3
... , TORONTO, Nov. 30 The Special Committee of Independent ... and JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, ... have entered into a settlement agreement in respect of the ... settlement provides among other things that: , until March ...
... , NEW YORK, Nov. 30 ... available in its catalogue: , Operating Tables - ... , Operating tables are primarily used to keep the ... to conduct the surgical procedure and, if necessary, enable ...
Cached Medicine Technology:Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3Reportlinker Adds Operating Tables - A World Market Review 2Reportlinker Adds Operating Tables - A World Market Review 3Reportlinker Adds Operating Tables - A World Market Review 4Reportlinker Adds Operating Tables - A World Market Review 5
The computer-optimized optical design produces large, brilliant images of high resolution....
Stryker bariatric laparoscopes set the standard in picture quality....
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
The Concept Plus also allows users to transfer large bottles, flasks and other equipment, quickly and efficiently. The front-loading interlock features class leading one touch operation and easy acce...
Medicine Products: